These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 16904876)

  • 1. Nuclear envelope defects in muscular dystrophy.
    Roux KJ; Burke B
    Biochim Biophys Acta; 2007 Feb; 1772(2):118-27. PubMed ID: 16904876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear envelope dystrophies show a transcriptional fingerprint suggesting disruption of Rb-MyoD pathways in muscle regeneration.
    Bakay M; Wang Z; Melcon G; Schiltz L; Xuan J; Zhao P; Sartorelli V; Seo J; Pegoraro E; Angelini C; Shneiderman B; Escolar D; Chen YW; Winokur ST; Pachman LM; Fan C; Mandler R; Nevo Y; Gordon E; Zhu Y; Dong Y; Wang Y; Hoffman EP
    Brain; 2006 Apr; 129(Pt 4):996-1013. PubMed ID: 16478798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The nuclear envelope in muscular dystrophy and cardiovascular diseases.
    Burke B; Mounkes LC; Stewart CL
    Traffic; 2001 Oct; 2(10):675-83. PubMed ID: 11576443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear envelope proteins and associated diseases.
    Nagano A; Arahata K
    Curr Opin Neurol; 2000 Oct; 13(5):533-9. PubMed ID: 11073359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathological changes of the myonuclear fibrous lamina and internal nuclear membrane in two cases of autosomal dominant limb-girdle muscular dystrophy with atrioventricular conduction disturbance (LGMD1B).
    Matsubara S; Kitaguchi T
    Acta Neuropathol; 2004 Feb; 107(2):111-8. PubMed ID: 14673599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of A-type lamin expression compromises nuclear envelope integrity leading to muscular dystrophy.
    Sullivan T; Escalante-Alcalde D; Bhatt H; Anver M; Bhat N; Nagashima K; Stewart CL; Burke B
    J Cell Biol; 1999 Nov; 147(5):913-20. PubMed ID: 10579712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemistry on a panel of Emery-Dreifuss muscular dystrophy samples reveals nuclear envelope proteins as inconsistent markers for pathology.
    Le Thanh P; Meinke P; Korfali N; Srsen V; Robson MI; Wehnert M; Schoser B; Sewry CA; Schirmer EC
    Neuromuscul Disord; 2017 Apr; 27(4):338-351. PubMed ID: 28214269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lamin A N-terminal phosphorylation is associated with myoblast activation: impairment in Emery-Dreifuss muscular dystrophy.
    Cenni V; Sabatelli P; Mattioli E; Marmiroli S; Capanni C; Ognibene A; Squarzoni S; Maraldi NM; Bonne G; Columbaro M; Merlini L; Lattanzi G
    J Med Genet; 2005 Mar; 42(3):214-20. PubMed ID: 15744034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nesprin-1 and -2 are involved in the pathogenesis of Emery Dreifuss muscular dystrophy and are critical for nuclear envelope integrity.
    Zhang Q; Bethmann C; Worth NF; Davies JD; Wasner C; Feuer A; Ragnauth CD; Yi Q; Mellad JA; Warren DT; Wheeler MA; Ellis JA; Skepper JN; Vorgerd M; Schlotter-Weigel B; Weissberg PL; Roberts RG; Wehnert M; Shanahan CM
    Hum Mol Genet; 2007 Dec; 16(23):2816-33. PubMed ID: 17761684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emery-Dreifuss muscular dystrophy, laminopathies, and other nuclear envelopathies.
    Bonne G; Quijano-Roy S
    Handb Clin Neurol; 2013; 113():1367-76. PubMed ID: 23622360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunocytochemistry of nuclear domains and Emery-Dreifuss muscular dystrophy pathophysiology.
    Maraldi NM; Lattanzi G; Sabatelli P; Ognibene A; Columbaro M; Capanni C; Rutigliano C; Mattioli E; Squarzoni S
    Eur J Histochem; 2003; 47(1):3-16. PubMed ID: 12685553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerin deficiency at the nuclear membrane in patients with Emery-Dreifuss muscular dystrophy.
    Nagano A; Koga R; Ogawa M; Kurano Y; Kawada J; Okada R; Hayashi YK; Tsukahara T; Arahata K
    Nat Genet; 1996 Mar; 12(3):254-9. PubMed ID: 8589715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Silico and In Vivo Analysis of Amino Acid Substitutions That Cause Laminopathies.
    Hinz BE; Walker SG; Xiong A; Gogal RA; Schnieders MJ; Wallrath LL
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerin Represses STAT3 Signaling through Nuclear Membrane-Based Spatial Control.
    Lee B; Lee S; Lee Y; Park Y; Shim J
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34206382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscular Dystrophy Mutations Impair the Nuclear Envelope Emerin Self-assembly Properties.
    Herrada I; Samson C; Velours C; Renault L; Östlund C; Chervy P; Puchkov D; Worman HJ; Buendia B; Zinn-Justin S
    ACS Chem Biol; 2015 Dec; 10(12):2733-42. PubMed ID: 26415001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear envelope proteins and neuromuscular diseases.
    Ostlund C; Worman HJ
    Muscle Nerve; 2003 Apr; 27(4):393-406. PubMed ID: 12661041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant intracellular targeting and cell cycle-dependent phosphorylation of emerin contribute to the Emery-Dreifuss muscular dystrophy phenotype.
    Ellis JA; Craxton M; Yates JR; Kendrick-Jones J
    J Cell Sci; 1998 Mar; 111 ( Pt 6)():781-92. PubMed ID: 9472006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear membrane protein emerin: roles in gene regulation, actin dynamics and human disease.
    Wilson KL; Holaska JM; Montes de Oca R; Tifft K; Zastrow M; Segura-Totten M; Mansharamani M; Bengtsson L
    Novartis Found Symp; 2005; 264():51-58; discussion 58-62, 227-30. PubMed ID: 15773747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerinopathy and laminopathy clinical, pathological and molecular features of muscular dystrophy with nuclear envelopathy in Japan.
    Astejada MN; Goto K; Nagano A; Ura S; Noguchi S; Nonaka I; Nishino I; Hayashi YK
    Acta Myol; 2007 Dec; 26(3):159-64. PubMed ID: 18646565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear envelope alterations in fibroblasts from LGMD1B patients carrying nonsense Y259X heterozygous or homozygous mutation in lamin A/C gene.
    Muchir A; van Engelen BG; Lammens M; Mislow JM; McNally E; Schwartz K; Bonne G
    Exp Cell Res; 2003 Dec; 291(2):352-62. PubMed ID: 14644157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.